Tag: Cancer: Breast
SABCS: Imlunestrant Tied to Improved PFS for ER-Positive, HER2-Negative Breast Cancer With ESR1 Mutations
Imlunestrant leads to significantly longer progression-free survival among those with ESR1 mutations, but not in overall population
2004 to 2021 Saw Increase in Distant-Stage Breast Cancer Incidence
Significant increase seen in incidence rates at presentation for women overall, and for those aged 20 to 39, 40 to 74, and 75 years or older
Low-Dose Oral Minoxidil Effective for Alopecia in Breast Cancer
All patients receiving surgery/radiotherapy alone or with chemotherapy had improvement or stability of alopecia with LDOM
Adding Previous Screening Mammogram Images Improves Cancer Prediction
Five-year AUC with addition of previous mammogram images improves current visit mammogram AUC
Neoantigen DNA Vaccines Safe, Induce Response in Triple-Negative Breast Cancer
Fourteen of 18 patients had neoantigen-specific T-cell responses; recurrence-free survival was 87.5 percent at 36 months
Inavolisib + Palbociclib-Fulvestrant Improves Survival in Advanced Breast Cancer
Inavolisib leads to significantly longer progression-free survival, with no increase seen in incidence of toxic events
Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast Cancer
Improved three-year disease-free and recurrence-free survival seen with intensive chemotherapy regimen
Guideline-Concordant Care Less Likely With Non-Hispanic Black Race
Findings seen in older patients with breast cancer; non-Hispanic Black patients also less likely to have timely initiation of treatment
Medicaid Expansion Increases Guideline-Concordant Treatment for Breast Cancer
Increase seen in receipt of guideline-concordant treatment for women newly diagnosed with HR-negative, HER2-positive breast cancer
No Objective Improvement Seen in Cognitive Function With Exercise During Chemo
Significant differences seen in four of six self-reported cognitive function outcomes favoring aerobic exercise initiated with chemo
